Table 2.
Number of Patients (BP/MP/UC) | Biphasic | Monophasic | Unclassifiable | |
---|---|---|---|---|
CD5 | 16/14/15 | 6 | 7 | 13 |
CD23 | 15/14/16 | 0 | 14 | 13 |
CD10 | 15/14/16 | 0 | 0 | 0 |
CD43 | 16/14/12 | 0 | 21^ | 25^^ |
Bcl-2 | 16/14/14 | 100 | 100 | 100 |
Bcl-6 | 16/14/16 | 0 | 7 | 0 |
IRF4/MUM1 | 15/14/16 | 27 | 29 | 31 |
IgD | 15/14/14 | 93 | 64# | 57* |
Cyclin D1 | 16/14/16 | 0 | 0 | 0 |
CD5(−), CD10(−), CD43(−), CD23(−) | 15/14/13 | 94 | 64# | 69 |
IgD(+), CD5(−), CD10(−), CD43(−), CD23(−) | 15/14/13 | 87 | 29** | 23** |
p < 0.04 vs. BP
p < 0.003 vs. BP
p = 0.08 vs. BP
p = 0.09 vs. BP
p = 0.07 vs BP
BP-biphasic, MP-monophasic, UC-unclassifiable